THROMBOTARGETS EUROPE S.L.
Thrombotargets is focused on the development of new therapeutical compounds in the hemostasis and coagulation field. Its proprietary technologies and expertise have led to an innovative pipeline. The topical hemostat TT-173, Thrombotargets lead compound, is at present in clinical Phase III.
THROMBOTARGETS EUROPE S.L.
Industry:
Biotechnology Therapeutics
Founded:
2005-01-01
Address:
Barcelona, Catalonia, Spain
Country:
Spain
Website Url:
http://www.thrombotargets.com
Status:
Active
Contact:
+34 93 664 20 40
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible WordPress Apache Wordpress Plugins Slider Revolution LayerSlider Responsive Shockwave Flash Embed
Similar Organizations
Origin
Origin is a privately held, clinical-stage biotechnology company.
Akashi Therapeutics
Akashi Therapeutics is a clinical stage biopharmaceutical company.
Gubra
Gubra is a privately-held biotech company
Human stem cells institute PJSC
Human stem cells institute PJSC is a privately held company operates as a biotech company.
Official Site Inspections
http://www.thrombotargets.com
- Host name: premium323-4.web-hosting.com
- IP address: 66.29.153.66
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
